Literature DB >> 8524315

The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities.

W Min1, S Ghosh, P Lengyel.   

Abstract

The antimicrobial, immunomodulatory, and cell growth-regulatory activities of the interferons are mediated by interferon-inducible proteins. One of these is p202, a nuclear protein that is encoded by the Ifi 202 gene from the interferon-activatable gene 200 cluster. Overexpression of p202 in transfected cells slows down cell proliferation. As shown earlier, p202 binds to the hypophosphorylated form of the retinoblastoma susceptibility protein. Here we report that p202 inhibits the activities of the NF-kappa B and the AP-1 enhancers both in transiently transfected cells and in transfected stable cell lines overexpressing p202. Furthermore, p202 binds the NF-kappa B p50 and p65 and the AP-1 c-Fos and c-Jun transcription factors in vitro and in vivo. NF-kappa B, c-Fos, and c-Jun participate in the transcription of various cellular and viral genes, and thus p202 can modulate the expression of these genes in response to interferons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8524315      PMCID: PMC231010          DOI: 10.1128/MCB.16.1.359

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  70 in total

Review 1.  Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors.

Authors:  M Karin
Journal:  Curr Opin Cell Biol       Date:  1994-06       Impact factor: 8.382

Review 2.  DNA-binding domains: targets for viral and cellular regulators.

Authors:  S Wagner; M R Green
Journal:  Curr Opin Cell Biol       Date:  1994-06       Impact factor: 8.382

3.  The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.

Authors:  V J Palombella; O J Rando; A L Goldberg; T Maniatis
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

Review 4.  Biochemistry of interferons and their actions.

Authors:  P Lengyel
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

5.  Inhibition of NF-kappa B by sodium salicylate and aspirin.

Authors:  E Kopp; S Ghosh
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

6.  Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras.

Authors:  A Maran; R K Maitra; A Kumar; B Dong; W Xiao; G Li; B R Williams; P F Torrence; R H Silverman
Journal:  Science       Date:  1994-08-05       Impact factor: 47.728

7.  An HMG-like protein that can switch a transcriptional activator to a repressor.

Authors:  N Lehming; D Thanos; J M Brickman; J Ma; T Maniatis; M Ptashne
Journal:  Nature       Date:  1994-09-08       Impact factor: 49.962

8.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

9.  AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes.

Authors:  M Rincón; R A Flavell
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

10.  A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B.

Authors:  E B Traenckner; S Wilk; P A Baeuerle
Journal:  EMBO J       Date:  1994-11-15       Impact factor: 11.598

View more
  34 in total

Review 1.  Transcription and growth regulatory functions of the HIN-200 family of proteins.

Authors:  R W Johnstone; J A Trapani
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins.

Authors:  Chuan-ju Liu; Bo Ding; Hong Wang; Peter Lengyel
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

3.  MyoD-dependent induction during myoblast differentiation of p204, a protein also inducible by interferon.

Authors:  C j Liu; H Wang; Z Zhao; S Yu; Y B Lu; J Meyer; G Chatterjee; S Deschamps; B A Roe; P Lengyel
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  The interferon-inducible nucleolar p204 protein binds the ribosomal RNA-specific UBF1 transcription factor and inhibits ribosomal RNA transcription.

Authors:  C J Liu; H Wang; P Lengyel
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

5.  Expression of IFI 16 in epithelial cells and lymphoid tissues.

Authors:  Wu Wei; Christopher J P Clarke; Gino R Somers; Kim S Cresswell; Kate A Loveland; Joseph A Trapani; Ricky W Johnstone
Journal:  Histochem Cell Biol       Date:  2002-12-20       Impact factor: 4.304

6.  Inhibition of vascular smooth muscle cell proliferation and intimal hyperplasia by gene transfer of beta-interferon.

Authors:  D Stephan; H San; Z Y Yang; D Gordon; S Goelz; G J Nabel; E G Nabel
Journal:  Mol Med       Date:  1997-09       Impact factor: 6.354

7.  Inhibition of E2F-mediated transcription by p202.

Authors:  D Choubey; S J Li; B Datta; J U Gutterman; P Lengyel
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

8.  Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways.

Authors:  A H Wong; N W Tam; Y L Yang; A R Cuddihy; S Li; S Kirchhoff; H Hauser; T Decker; A E Koromilas
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

Review 9.  Systemic lupus erythematosus and increased risk to develop B cell malignancies: role of the p200-family proteins.

Authors:  Sudhakar Veeranki; Divaker Choubey
Journal:  Immunol Lett       Date:  2010-06-26       Impact factor: 3.685

Review 10.  Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility.

Authors:  Divaker Choubey
Journal:  Immunol Lett       Date:  2012-07-24       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.